Navigation Links
China Pharma Holdings, Inc. Announces Record 2007 Year End Results
Date:3/31/2008

f revenue during the fourth quarter of 2006. The Company recognized tax credits of $162,872 and $730,560 for 2007 and 2006, respectively. After taking these credits into account, net income for the fourth quarter of 2007 increased 15.8% to $4.0 million, up from $3.5 million in the same period last year. The net profit margin was 44% for the fourth quarter of 2007, versus 43% for the fourth quarter of 2006. Diluted earnings per share (EPS) in the fourth quarter of 2007 were $0.10. Earnings per share were $0.10 in fourth quarter of 2006 as well. The weighted average share counts used to calculate diluted EPS for the fourth quarter of 2007 and 2006 were 37.3 million and 34.7 million, respectively.

Ms. Zhilin Li, President and Chief Executive Officer of China Pharma commented, "The China SFDA implemented a new regulation (Provisions for Drug Registration) for the new drug approval process on October 1st, 2007. In December 2007, we received approval of Bumetanide from the Chinese SFDA. We are encouraged by this very positive sign that the SFDA has resumed its procedures for approving new drugs and expect that several additional drugs in our development pipeline will be approved in 2008. Going forward, we will continue to focus on increasing production output to fully utilize our 8 modern GMP certified production lines. Our future growth will be driven by leveraging our R&D capabilities, which are supplemented through relationships with various pharmaceutical research institutions, to extend our development pipeline while commercializing new drugs, and further expanding our distribution network to broaden market penetration. We are positioned extremely well to capitalize on the long-term secular growth drivers in place in the pharmaceutical industry, which include the rapid economic growth empowering consumers to receive better treatments, which will be supported by an increase in government spending for individual healthcare in China and the market expansion of th
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... ... Ralco is honored to announce that it is the primary sponsor of ... 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience where the public ... daily lives. This unique exhibit also features a birthing center for fair goers to ...
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry ... market with a focus on the Chinese situation. Major companies included in the propanol ... Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides ...
(Date:7/30/2015)... SAN DIEGO, July 30, 2015   Senomyx , ... proprietary taste science technologies to discover, develop, and commercialize ... supply industries, today reported financial results for the second ... half of 2015, we remain on track to achieve ... and Chief Executive Officer of the Company. "Since our ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... Hollingsworth & Vose,Company (H&V), a leading ... introduced its HVision(TM) technology platform, a collaborative,process ... of,breakthrough products. "HVision will provide H&V ... a new generation of products that exceed ...
... Corporation (OTC,Bulletin Board: KDUS.OB) announced today financial results for the ... the third quarter of 2007 and for the same period,in ... $240,227, compared to,net income of $200,335 for the same period ... third quarter of 2007 and for the same period in,2006. ...
... Stock Exchange: EVT) Reported Today Results for,the First ... OXFORD, England, November 13 /PRNewswire-FirstCall/,-- Highlights: ... - Compelling results achieved in two proof-of-concept ... 201 - Sale of the Chemical Development ...
Cached Biology Technology:H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products 2Cadus Reports Third Quarter 2007 Results 2Cadus Reports Third Quarter 2007 Results 3Cadus Reports Third Quarter 2007 Results 4Evotec Reports Third Quarter 2007 Results 2Evotec Reports Third Quarter 2007 Results 3Evotec Reports Third Quarter 2007 Results 4Evotec Reports Third Quarter 2007 Results 5Evotec Reports Third Quarter 2007 Results 6Evotec Reports Third Quarter 2007 Results 7Evotec Reports Third Quarter 2007 Results 8
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced a new Match-in-Sensor™ ... hardware encapsulated fingerprint sensor and matching solution. ... literally off the grid, isolating fingerprint image ... the fingerprint sensor to provide ultimate protection ...
(Date:7/7/2015)... 30, 2015 Research ... addition of the "Capacitive Fingerprint Sensors Patent ... To this date, fingerprint sensing technology is the ... sensors are well developed. This patent landscape focuses ... The domain of capacitive fingerprint sensors is ...
(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... collective efforts to develop new drugs, the pharmaceuticals industry ... application of natural biological transformation processes. One of the ... cells in a bioreactor filled with a liquid culture ... regulations, the conditions inside the bioreactor need to be ...
... various Earth system science disciplines recently gathered to address ... in the future? Of course, possible answers to ... changing climatic conditions were to alter local vegetation, how ... Answering these questions with certainty would allow us to ...
... of BioScience, researchers present a sophisticated new ... ethanol on greenhouse gas emissions. The study, conducted by ... focuses on how mandated increases in production of the ... domestically and elsewhere. In response to the increased demand ...
Cached Biology News:Clean sampling from bioreactors 2Networking initiative to support interdisciplinary research 2Networking initiative to support interdisciplinary research 3More maize ethanol may boost greenhouse gas emissions 2
... is a recombinant protein that has been shown ... the preparation of cDNA by reverse transcription, in ... synthesis. RNA Safe Inhibitor tightly binds RNases in ... of eukaryotic RNases such as RNase A, RNase ...
...
... RNase Inhibitor (Ribonuclease inhibitor) ... enzyme used to inhibit RNase ... DNase or endonuclease activity. , ... degradation of RNA template ...
...
Biology Products: